薬物スクリーニングの世界市場予測(~2025):製品別(消耗品、尿検査装置、分析、飲酒、クロマトグラフィー)、サービス別、サンプル種類別(尿、呼気)、エンドユーザー別(職場、研究所、刑事司法、病院)

【英語タイトル】Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2025

MarketsandMarketsが出版した調査資料(MD 3239)・商品コード:MD 3239
・発行会社(調査会社):MarketsandMarkets
・発行日:2020年12月2日
・ページ数:185
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥663,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥891,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,092,100見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
MarketsandMarkets社は薬物スクリーニングの世界市場が2020年45億ドルから2025年100億ドルまで、年平均17.3%成長すると予想しています。本調査レポートは、薬物スクリーニングの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(薬物スクリーニングサービス、薬物スクリーニング製品)分析、サンプル種類別(尿サンプル、呼吸サンプル、経口液サンプル、毛髪サンプル、その他サンプル)分析、エンドユーザー別(職場、薬物検査ラボ、刑事司法制度・法執行機関、病院、薬物治療センター)分析、地域別分析、競争状況、企業評価マトリックスなどの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・薬物スクリーニングの世界市場規模:製品・サービス別(薬物スクリーニングサービス、薬物スクリーニング製品)
・薬物スクリーニングの世界市場規模:サンプル種類別(尿サンプル、呼吸サンプル、経口液サンプル、毛髪サンプル、その他サンプル)
・薬物スクリーニングの世界市場規模:エンドユーザー別(職場、薬物検査ラボ、刑事司法制度・法執行機関、病院、薬物治療センター)
・薬物スクリーニングの世界市場規模:地域別
・競争状況
・企業評価マトリックス
【レポートの概要】

“The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period.”
Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.

“Drug screening services are expected to grow at the highest CAGR during the forecast period.”
Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

“By sample type, urine samples are expected to dominate the market during the forecast period.”
The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

“North America will dominate the market during the forecast period.”
Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug screening market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
• By Designation – C-level: 25%, D-level: 44%, and Others: 33%
• By Region – North America: 40%, Europe: 29%, Asia Pacific: 19%, and Rest of the World: 12%

List of Companies Profiled in the Report:
• LabCorp (US)
• Alere (US)
• Thermo Fisher (US)
• Drägerwerk (Germany)
• Quest Diagnostics (US)
• Alfa Scientific Designs (US)
• Lifeloc (US)
• MPD, Inc. (US)
• OraSure (US)
• Omega Laboratories (US)
• Premier Biotech (US)
• Psychemedics (US)
• Roche (Switzerland)
• Shimadzu (Japan)
• Seimens Healthineers (US)
• American Bio Medica Corporation (US)
• Sciteck, Inc. (US)
• ACM Global Laboratories (US)
• CareHealth America (US)
• Clinical Reference Laboratory (US)

Research Coverage:
This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on drug screening offered by the top 20 players in the drug screeningmarket. The report analyses the drug screeningmarket by product and service, sample type, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening fmarket.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 MARKET STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.2 SECONDARY DATA 33
2.2.1 KEY DATA FROM SECONDARY SOURCES 34
2.3 PRIMARY DATA 34
2.3.1 PRIMARY SOURCES 35
2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS 36
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY,
DESIGNATION, AND REGION 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER AND REGION 36
2.4 MARKET ESTIMATION 37
2.4.1 BOTTOM-UP APPROACH 37
2.4.2 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION 39
FIGURE 4 DRUG SCREENING MARKET: TOP-DOWN APPROACH 39
2.4.3 GROWTH FORECAST 39
2.5 MARKET BREAKDOWN & DATA TRIANGULATION 40
FIGURE 5 DATA TRIANGULATION METHODOLOGY 40
2.6 ASSUMPTIONS FOR THE STUDY 41
3 EXECUTIVE SUMMARY 42
FIGURE 6 DRUG SCREENING SERVICES MARKET TO RECORD HIGHEST CAGR DURING 2020–2025 42
FIGURE 7 ANALYTICAL INSTRUMENTS SEGMENT TO LEAD THE DRUG SCREENING PRODUCTS MARKET, 2020–2025 (USD BILLION) 43
FIGURE 8 WORKPLACES TO SHOW THE HIGHEST GROWTH IN THE END-USER MARKET, 2020–2025 (USD BILLION) 44
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE DRUG SCREENING MARKET 45
4 PREMIUM INSIGHTS 46
4.1 ATTRACTIVE OPPORTUNITIES IN THE DRUG SCREENING MARKET 46
FIGURE 10 GROWING CONSUMPTION OF DRUGS AND ALCOHOL TO DRIVE MARKET GROWTH 46
4.2 DRUG SCREENING MARKET, BY PRODUCT & SERVICE 47
FIGURE 11 SERVICES SEGMENT TO REGISTER HIGHEST CAGR DURING
2020–2025 (USD BILLION) 47
4.3 DRUG SCREENING MARKET, BY SAMPLE TYPE 47
FIGURE 12 ORAL FLUID SAMPLES SEGMENT TO WITNESS HIGHEST CAGR,
2020–2025 (USD BILLION) 47
4.4 DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT 48
FIGURE 13 INDIA TO WITNESS HIGHEST CAGR DURING THE FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 14 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.3 MARKET DYNAMICS 50
5.3.1 DRIVERS 50
5.3.1.1 Growing drug and alcohol consumption 50
5.3.1.2 Enforcement of stringent laws mandating drug and alcohol testing 50
5.3.1.3 Regulatory approvals and product & service launches 51
TABLE 1 KEY PRODUCT & SERVICE LAUNCHES (2014–2017) 51
TABLE 2 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES 51
5.3.2 RESTRAINTS 52
5.3.2.1 Ban on alcohol consumption in several Islamic countries 52
5.3.2.2 Prohibition on workplace drug testing in some countries 52
5.3.3 OPPORTUNITIES 52
5.3.3.1 Oral fluid testing 52
5.3.3.2 Fingerprint-based drug screening 52
5.3.3.3 Emerging economies 53
5.3.4 CHALLENGES 53
5.3.4.1 Accuracy and specificity concerns related to breathalyzers 53
5.4 VALUE CHAIN ANALYSIS 54
FIGURE 15 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 54
5.5 ECOSYSTEM ANALYSIS OF THE DRUG SCREENING PRODUCTS MARKET 55
FIGURE 16 ECOSYSTEM ANALYSIS 55
5.6 COVID-19 IMPACT ON THE DRUG SCREENING MARKET 55

6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE 56
6.1 INTRODUCTION 57
TABLE 3 DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 57
6.2 DRUG SCREENING SERVICES 57
6.2.1 GROWING DRUG CONSUMPTION AND STRINGENT LAWS HAVE ENSURED DEMAND SPIKE FOR SERVICES 57
TABLE 4 DRUG SCREENING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 58
6.3 DRUG SCREENING PRODUCTS 58
TABLE 5 DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 58
6.3.1 ANALYTICAL INSTRUMENTS 58
TABLE 6 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS,
BY TYPE, 2018–2025 (USD MILLION) 59
TABLE 7 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS,
BY REGION, 2018–2025 (USD MILLION) 59
6.3.1.1 Breathalyzers 59
6.3.1.1.1 Law enforcement agencies widely use breathalyzers 59
TABLE 8 BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 60
TABLE 9 BREATHALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION) 60
6.3.1.1.2 Fuel-cell breathalyzers 60
TABLE 10 FUEL-CELL BREATHALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 61
6.3.1.1.3 Semiconductor breathalyzers 61
TABLE 11 SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 61
6.3.1.1.4 Other breathalyzers 62
TABLE 12 OTHER BREATHALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 62
6.3.1.2 Immunoassay analyzers 62
6.3.1.2.1 North America is the largest market for immunoassay analyzers 62
TABLE 13 IMMUNOASSAY ANALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 63
6.3.1.3 Chromatography instruments 63
6.3.1.3.1 Chromatography shows higher accuracy than immunoassays 63
TABLE 14 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 63
6.3.2 RAPID TESTING DEVICES 64
TABLE 15 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 64
TABLE 16 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES,
BY REGION, 2018–2025 (USD MILLION) 64
6.3.2.1 Urine testing devices 64
6.3.2.1.1 Urine testing provides results within minutes and is used in a wide range of applications 64
TABLE 17 URINE TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 65
TABLE 18 URINE TESTING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 65
6.3.2.1.2 Drug testing cups 65
TABLE 19 DRUG TESTING CUPS MARKET, BY REGION, 2018–2025 (USD MILLION) 66
6.3.2.1.3 Dip cards 66
TABLE 20 DIP CARDS MARKET, BY REGION, 2018–2025 (USD MILLION) 66
6.3.2.1.4 Drug testing cassettes 66
TABLE 21 DRUG TESTING CASSETTES MARKET, BY REGION,
2018–2025 (USD MILLION) 67
6.3.2.2 Oral fluid testing devices 67
6.3.2.2.1 Short detection windows, noninvasive nature, and low chance of sample tampering have ensured interest in oral fluid testing 67
TABLE 22 ORAL FLUID TESTING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 67
6.3.3 CONSUMABLES 68
TABLE 23 DRUG SCREENING CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 68
TABLE 24 DRUG SCREENING CONSUMABLES MARKET, BY REGION,
2018–2025 (USD MILLION) 68
6.3.3.1 Assay kits 68
6.3.3.1.1 Immunoassay kits provide a rapid, inexpensive method to screen samples 68
TABLE 25 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 69
6.3.3.2 Sample collection devices 69
6.3.3.2.1 APAC market for sample collection devices to see high growth 69
TABLE 26 SAMPLE COLLECTION DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 69
6.3.3.3 Calibrators & controls 70
6.3.3.3.1 Thermo Fisher Scientific is a prominent manufacturer of calibrators & controls 70
TABLE 27 CALIBRATORS & CONTROLS MARKET, BY REGION,
2018–2025 (USD MILLION) 70
6.3.3.4 Other consumables 70
TABLE 28 OTHER CONSUMABLES MARKET, BY REGION,
2018–2025 (USD MILLION) 70
7 DRUG SCREENING MARKET, BY SAMPLE TYPE 71
7.1 INTRODUCTION 72
TABLE 29 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 72
7.2 URINE SAMPLES 72
7.2.1 EASE OF COLLECTION AND WELL-DEVELOPED TECHNOLOGY HAVE SUPPORTED THE USE OF URINE SAMPLES 72
TABLE 30 DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION,
2018–2025 (USD MILLION) 73
7.3 BREATH SAMPLES 73
7.3.1 BREATH ALCOHOL TESTS SEE WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS 73
TABLE 31 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION,
2018–2025 (USD MILLION) 73
7.4 ORAL FLUID SAMPLES 74
7.4.1 NONINVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION HAVE SUPPORTED RELIANCE ON ORAL SAMPLES 74
TABLE 32 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION,
2018–2025 (USD MILLION) 74
7.5 HAIR SAMPLES 75
7.5.1 HAIR SAMPLES CAN PROVIDE INSIGHTS INTO LONG-TERM DRUG USE 75
TABLE 33 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION,
2018–2025 (USD MILLION) 75
7.6 OTHER SAMPLES 75
TABLE 34 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION,
2018–2025 (USD MILLION) 76
8 DRUG SCREENING MARKET, BY END USER 77
8.1 INTRODUCTION 78
TABLE 35 DRUG SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION) 78
8.2 WORKPLACES 78
8.2.1 WORKPLACES TO SHOW THE HIGHEST GROWTH OF ALL END-USER SEGMENTS 78
TABLE 36 DRUG SCREENING MARKET FOR WORKPLACES, BY REGION,
2018–2025 (USD MILLION) 79
8.3 DRUG TESTING LABORATORIES 79
8.3.1 RISING NUMBER OF DRUG ABUSE CASES AND DEVELOPMENT OF SPECIALIZED ASSAYS AND TESTS SUPPORT MARKET GROWTH 79
TABLE 37 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2018–2025 (USD MILLION) 79
8.4 CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES 80
8.4.1 URINE IS THE MOST COMMONLY USED SAMPLE IN CRIMINAL JUSTICE SYSTEMS 80
TABLE 38 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018–2025 (USD MILLION) 80
8.5 HOSPITALS 81
8.5.1 RISING DRUG ABUSE INCIDENCE HAS RESULTED IN AN INCREASE IN EMERGENCY DEPARTMENT VISITS 81
TABLE 39 DRUG SCREENING MARKET FOR HOSPITALS, BY REGION,
2018–2025 (USD MILLION) 81
8.6 DRUG TREATMENT CENTERS 81
8.6.1 AVAILABILITY OF GOVERNMENT SUPPORT IS A KEY GROWTH DRIVER 81
TABLE 40 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2018–2025 (USD MILLION) 82
8.7 INDIVIDUAL USERS 82
8.7.1 PERSONAL BREATHALYZERS HAVE SEEN GROWING ADOPTION 82
TABLE 41 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION,
2018–2025 (USD MILLION) 82
8.8 PAIN MANAGEMENT CENTERS 83
8.8.1 RISING SUBSTANCE ABUSE HAS SUPPORTED DRUG TESTING ACTIVITY IN PAIN MANAGEMENT APPLICATIONS 83
TABLE 42 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2018–2025 (USD MILLION) 83
8.9 SCHOOLS & COLLEGES 83
8.9.1 WHILE SOME COUNTRIES SUPPORT DRUG TESTS IN SCHOOLS & COLLEGES, OTHERS ARE OPPOSED OR HAVE BANNED TESTING 83
TABLE 43 DRUG SCREENING MARKET FOR SCHOOLS & COLLEGES, BY REGION,
2018–2025 (USD MILLION) 84
9 DRUG SCREENING MARKET, BY REGION 85
9.1 INTRODUCTION 86
TABLE 44 DRUG SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION) 86
9.2 NORTH AMERICA 87
FIGURE 17 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT 87
TABLE 45 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 88
TABLE 46 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 88
TABLE 47 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 88
TABLE 48 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 89
TABLE 49 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 89
TABLE 50 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 89
TABLE 51 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 90
TABLE 52 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 90
TABLE 53 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 90
TABLE 54 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 91
9.2.1 US 91
9.2.1.1 The US holds the largest share of the market in North America 91
TABLE 55 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 92
TABLE 56 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 92
TABLE 57 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 93
TABLE 58 US: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 59 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 60 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 61 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 62 US: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 94
TABLE 63 US: DRUG SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION) 94
9.2.2 CANADA 95
9.2.2.1 Canada has no legislation governing drug and alcohol testing in the workplace 95
TABLE 64 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 96
TABLE 65 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 96
TABLE 66 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 96
TABLE 67 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 68 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 69 CANADA: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 70 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 71 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 98
TABLE 72 CANADA: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 98
9.3 EUROPE 99
TABLE 73 EUROPE: DRUG SCREENING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 99
TABLE 74 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 99
TABLE 75 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 99
TABLE 76 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 77 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 78 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 79 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 80 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 81 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 101
TABLE 82 EUROPE: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 101
9.3.1 GERMANY 102
9.3.1.1 Germany is the largest market for drug screening products & services in Europe 102
TABLE 83 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 102
TABLE 84 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 102
TABLE 85 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 86 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 87 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 88 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 89 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 90 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 104
TABLE 91 GERMANY: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 104
9.3.2 FRANCE 105
9.3.2.1 Cannabis and cocaine are the most widely used illicit substances in France 105
TABLE 92 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 105
TABLE 93 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 94 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 95 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 106
TABLE 96 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 97 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 98 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 99 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 107
TABLE 100 FRANCE: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 107
9.3.3 UK 108
9.3.3.1 Favorable government support is a prominent driver of market growth in the UK 108
TABLE 101 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 108
TABLE 102 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 103 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 104 UK: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 105 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 106 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 107 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 108 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 110
TABLE 109 UK: DRUG SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION) 110
9.3.4 ROE 111
TABLE 110 ROE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 111
TABLE 111 ROE: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 111
TABLE 112 ROE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 113 ROE: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 114 ROE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 115 ROE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 116 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 117 ROE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 113
TABLE 118 ROE: DRUG SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION) 113
9.4 APAC 114
FIGURE 18 APAC: DRUG SCREENING MARKET SNAPSHOT 114
TABLE 119 APAC: DRUG SCREENING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 115
TABLE 120 APAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 115
TABLE 121 APAC: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 122 APAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 123 APAC: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 124 APAC: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 125 APAC: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 126 APAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 127 APAC: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 117
TABLE 128 APAC: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 117
9.4.1 CHINA 118
9.4.1.1 China holds the largest share of the APAC market 118
TABLE 129 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 118
TABLE 130 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 131 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 132 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 133 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 134 CHINA: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 135 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 120
TABLE 136 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 120
TABLE 137 CHINA: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 120
9.4.2 JAPAN 121
9.4.2.1 Stringent laws and growing awareness are key market drivers in Japan 121
TABLE 138 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 121
TABLE 139 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 140 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 141 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 142 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 143 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 144 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 145 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 123
TABLE 146 JAPAN: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 123
9.4.3 INDIA 124
9.4.3.1 India is among the fastest-growing segments of the drug screening market 124
TABLE 147 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 124
TABLE 148 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 149 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 150 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 151 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 152 INDIA: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 153 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 154 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 126
TABLE 155 INDIA: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 126
9.4.4 ROAPAC 127
TABLE 156 ROAPAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 127
TABLE 157 ROAPAC: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 158 ROAPAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 159 ROAPAC: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 160 ROAPAC: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 161 ROAPAC: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 162 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 163 ROAPAC: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 129
TABLE 164 ROAPAC: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 129
9.5 ROW 130
TABLE 165 ROW: DRUG SCREENING MARKET, BY REGION, 2018–2025 (USD MILLION) 130
TABLE 166 ROW: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 130
TABLE 167 ROW: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 168 ROW: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 169 ROW: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 170 ROW: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 171 ROW: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 172 ROW: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 173 ROW: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 132
TABLE 174 ROW: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 132
9.5.1 LATAM 133
9.5.1.1 Increasing incidence of drug overdose and favorable government support are key growth drivers in LATAM 133
TABLE 175 LATAM: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 133
TABLE 176 LATAM: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 177 LATAM: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 178 LATAM: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 179 LATAM: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 180 LATAM: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 181 LATAM: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 182 LATAM: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 135
TABLE 183 LATAM: DRUG SCREENING MARKET, BY END USER,
2018–2025 (USD MILLION) 135
9.5.2 MIDDLE EAST & AFRICA 136
9.5.2.1 Rising drug abuse and growing emphasis on testing support market growth in the MEA 136
TABLE 184 MEA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 136
TABLE 185 MEA: DRUG SCREENING PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 186 MEA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 187 MEA: BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 188 MEA: RAPID TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 189 MEA: URINE TESTING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 190 MEA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 191 MEA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2018–2025 (USD MILLION) 138
TABLE 192 MEA: DRUG SCREENING MARKET, BY END USER, 2018–2025 (USD MILLION) 138
10 COMPETITIVE LANDSCAPE 139
10.1 OVERVIEW 139
FIGURE 19 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020 139
FIGURE 20 MARKET EVOLUTION FRAMEWORK 140
10.2 COMPETITIVE SITUATIONS AND TRENDS 141
10.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020) 141
10.2.2 PRODUCT LAUNCHES (2017–2020) 142
10.2.3 APPROVALS (2017–2020) 142
10.2.4 EXPANSIONS (2017–2020) 143
10.2.5 ACQUISITIONS (2017-2020) 143
11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 144
11.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY 144
11.1.1 MARKET PLAYER RANKING, 2019 144
FIGURE 21 DRUG SCREENING SERVICES MARKET RANKING, BY KEY PLAYER, 2019 144
FIGURE 22 RAPID TESTING DEVICES MARKET RANKING, BY KEY PLAYER, 2019 144

11.2 COMPANY EVALUATION MATRIX 146
11.2.1 STARS 146
11.2.2 EMERGING LEADERS 146
11.2.3 PERVASIVE PLAYERS 146
11.2.4 PARTICIPANTS 146
FIGURE 23 MNM VENDOR DIVE COMPARISON MATRIX: DRUG SCREENING MARKET 147
11.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 148
11.3.1 PROGRESSIVE COMPANIES 148
11.3.2 STARTING BLOCKS 148
11.3.3 RESPONSIVE COMPANIES 148
11.3.4 DYNAMIC COMPANIES 148
FIGURE 24 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: DRUG SCREENING MARKET 149
11.4 COMPANY PROFILES 150
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.4.1 LABCORP 150
FIGURE 25 LABCORP: COMPANY SNAPSHOT (2019) 150
11.4.2 QUEST DIAGNOSTICS 152
FIGURE 26 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2019) 152
11.4.3 ALERE 155
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 155
11.4.4 ORASURE 158
FIGURE 28 ORASURE: COMPANY SNAPSHOTS (2019) 158
11.4.5 ALFA SCIENTIFIC DESIGNS 160
11.4.6 THERMO FISHER SCIENTIFIC 162
FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 162
11.4.7 DRÄGERWERK 165
FIGURE 30 DRÄGERWERK: COMPANY SNAPSHOT (2019) 165
11.4.8 LIFELOC 167
FIGURE 31 LIFELOC: COMPANY SNAPSHOT (2019) 167
11.4.9 MPD INC. 169
11.4.10 OMEGA LABORATORIES 170
11.4.11 PREMIER BIOTECH 171
11.4.12 PSYCHEMEDICS 172
FIGURE 32 PSYCHEMEDICS: COMPANY SNAPSHOT (2019) 172
11.4.13 ROCHE 174
FIGURE 33 ROCHE: COMPANY SNAPSHOT (2019) 174
11.4.14 SHIMADZU 176
FIGURE 34 SHIMADZU: COMPANY SNAPSHOT (2019) 176
11.4.15 SIEMENS HEALTHINEERS 178
FIGURE 35 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019) 178
11.4.16 AMERICAN BIO MEDICA CORPORATION 180
11.4.17 SCITECK, INC. 181
11.4.18 ACM GLOBAL LABORATORIES 182
11.4.19 CAREHEALTH AMERICA 183
11.4.20 CLINICAL REFERENCE LABORATORY 184
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 185
12.1 DISCUSSION GUIDE 185
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 189
12.3 AVAILABLE CUSTOMIZATIONS 191
12.4 RELATED REPORTS 191
12.5 AUTHOR DETAILS 192



★調査レポート[薬物スクリーニングの世界市場予測(~2025):製品別(消耗品、尿検査装置、分析、飲酒、クロマトグラフィー)、サービス別、サンプル種類別(尿、呼気)、エンドユーザー別(職場、研究所、刑事司法、病院)] (コード:MD 3239)販売に関する免責事項を必ずご確認ください。
★調査レポート[薬物スクリーニングの世界市場予測(~2025):製品別(消耗品、尿検査装置、分析、飲酒、クロマトグラフィー)、サービス別、サンプル種類別(尿、呼気)、エンドユーザー別(職場、研究所、刑事司法、病院)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆